Compare CENX & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CENX | TFX |
|---|---|---|
| Founded | 1995 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aluminum | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 5.3B |
| IPO Year | 2004 | 1994 |
| Metric | CENX | TFX |
|---|---|---|
| Price | $64.70 | $132.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 8 |
| Target Price | $65.67 | ★ $138.75 |
| AVG Volume (30 Days) | ★ 1.4M | 738.4K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.02% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.23 | N/A |
| Revenue | $1,893,200,000.00 | ★ $1,992,713,000.00 |
| Revenue This Year | $20.77 | $15.97 |
| Revenue Next Year | $14.58 | $5.15 |
| P/E Ratio | $18.62 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $15.13 | $100.18 |
| 52 Week High | $68.69 | $139.67 |
| Indicator | CENX | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 58.81 | 57.32 |
| Support Level | $45.49 | $102.20 |
| Resistance Level | $67.02 | $134.84 |
| Average True Range (ATR) | 4.01 | 4.26 |
| MACD | 0.10 | 0.02 |
| Stochastic Oscillator | 96.14 | 81.66 |
Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. The company produces high purity aluminum, standard-grade aluminum sow and tee bars, and value-added billet and foundry products. The company also owns a carbon anode production facility in the Netherlands.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.